FDA-approved, but no longer sold in the US.
No perspectives yet — be the first!
Be the first verified clinician to share a view on Apcitide.
100% anonymous · NPI-verifiedFDA status last checked Nov 11, 2026
A radioconjugate comprised of the small peptide apcitide labeled with the gamma-emitting technetium TC99m (metastable Tc-99). Apcitide binds to platelet glycoprotein (GP) GPIIb/IIIa receptors on the surface of activated platelets.
Apcitide
Approved by the FDA, but no longer sold in the US.
We have not yet attached proof for an evidence level.
No brand records are linked yet.
How it works. Proven facts and ideas still being studied are kept apart.
Not yet reviewed.
We have not yet attached proof for an evidence level.
Not yet reviewed.
FDA-approved, but no longer sold in the US (all US products discontinued). Applications: NDA020887.
Last verified: Nov 11, 2026
Share your perspective on Apcitide and help peers make informed prescribing decisions.
Your 45-second perspective helps thousands of colleagues.
Your real-world insights guide colleagues
Your identity stays private — only specialty/region shown
Compare your perspective to specialty peers
